CLONAL KARYOTYPE ABNORMALITIES AND CLINICAL-PROGRESS IN THE MYELODYSPLASTIC SYNDROME

被引:86
作者
GEDDES, AD
BOWEN, DT
JACOBS, A
机构
[1] Department of Haematology, University of Wales College of Medicine, Cardiff
关键词
D O I
10.1111/j.1365-2141.1990.tb07871.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Summary Summary Clonal karyotype abnormalities in 124 patients with myelodysplastic syndrome are reviewed. 36% of patients had abnormalities at referral, the most common being 5q ‐, +8 and lesions of chromosomes 7 and 20. Reduced survival was associated with the presence of either single or multiple clonal abnormalities at referral, abnormalities of chromosome 7 or 8 (either alone or with other lesions) and exclusively abnormal metaphases. The presence of 5q ‐alone did not appear to affect survival. Sequential studies were carried out in 77 patients of whom 12 showed karyotypic evolution. Reduced survival was observed in patients with an evolving karyotype but appeared to be due almost entirely to evolution in those patients whose initial karyotype was normal. Leukaemic transformation occurred more commonly in patients with an abnormal karyotype, particularly those with multiple abnormalities, and in patients with an evolving karyotype. Although the first appearance of an abnormal karyotype or an apparent evolution are important phenomena, it is probable that in some cases they merely represent expansion of a previously existing clone that has escaped detection. The distinction between true karyotypic evolution or clonal expansion and statistical variations due to small sample size and variability of samples may be difficult but needs to be taken into account in considering clinical significance. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:194 / 202
页数:9
相关论文
共 46 条
  • [1] THE PROGNOSTIC VALUE OF CHROMOSOME-STUDIES IN PATIENTS WITH THE PRELEUKEMIC SYNDROME (HEMATOPOIETIC DYSPLASIA)
    ANDERSON, RL
    BAGBY, GC
    [J]. LEUKEMIA RESEARCH, 1982, 6 (02) : 175 - 181
  • [2] CYTOGENETIC STUDY OF 88 CASES OF REFRACTORY-ANEMIA
    AYRAUD, N
    DONZEAU, M
    RAYNAUD, S
    LAMBERT, JC
    [J]. CANCER GENETICS AND CYTOGENETICS, 1983, 8 (03) : 243 - 248
  • [3] BARNETT G, 1986, MOL PHARMACOL, V29, P378
  • [4] FREQUENCY OF CONSTITUTIONAL CHROMOSOME ALTERATIONS IN PATIENTS WITH HEMATOLOGIC NEOPLASIAS
    BENITEZ, J
    VALCARCEL, E
    RAMOS, C
    AYUSO, C
    CASCOS, AS
    [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 24 (02) : 345 - 354
  • [5] PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, HR
    SULTAN, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 189 - 199
  • [6] BILLSTROM R, 1988, EUR J HAEMATOL, V41, P341
  • [7] CHRONIC MYELOGENOUS LEUKEMIA IN AN XYY MALE
    CHAGANTI, RSK
    JHANWAR, SC
    ARLIN, ZA
    CLARKSON, BD
    [J]. CANCER GENETICS AND CYTOGENETICS, 1982, 5 (03) : 223 - 226
  • [8] CHRONIC MYELOGENOUS LEUKEMIA IN THE MONOSOMIC CELL-LINE OF A FERTILE TURNER SYNDROME MOSAIC (45,X/46,XX)
    CHAGANTI, RSK
    BAILEY, RB
    JHANWAR, SC
    ARLIN, ZA
    CLARKSON, BD
    [J]. CANCER GENETICS AND CYTOGENETICS, 1982, 5 (03) : 215 - 221
  • [9] CLARK RE, 1988, CLIN GENET, V33, P418
  • [10] METHOTREXATE AND BONE-MARROW METAPHASES
    CUNNINGHAM, JJP
    POTTER, AM
    WATMORE, AE
    WINFIELD, DA
    [J]. CANCER GENETICS AND CYTOGENETICS, 1988, 33 (02) : 213 - 224